Loading chat...
MA S819
Bill
Status
Introduced
2/27/2025
Primary Sponsor
Pavel Payano
Click for details
AI Summary
- Prohibits insurers and drug coverage plans from reimbursing 340B-covered entities or their contract pharmacies at lower rates than non-340B pharmacies for the same drugs
- Bans discriminatory fees, chargebacks, clawbacks, dispensing fees, and pharmacy network restrictions against 340B entities and contract pharmacies
- Prohibits requiring 340B drug claims to include identifiers marking them as 340B purchases, except for Medicaid claims
- Bars drug manufacturers and distributors from restricting 340B drug acquisition or delivery to contract pharmacies, or requiring data submission as a condition of drug access
- Protects patient choice by preventing insurers from steering patients away from receiving drugs at 340B-covered entities or their contract pharmacies
Legislative Description
Prohibiting discrimination against 340b drug discount program participants
Last Action
Bill reported favorably by committee and referred to the Joint Committee on Health Care Financing
12/4/2025
Committee Referrals
Health Care Financing12/4/2025
Financial Services2/27/2025
Full Bill Text
No bill text available